World's Best Scientists 2026 revealed!
Stephen J. Russell

Stephen J. Russell

Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
110
Citations
33203
World Ranking
244
National Ranking
112

Medicine

D-Index
122
Citations
49962
World Ranking
3499
National Ranking
1926

Stephen J. Russell publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Stephen J. Russell sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 560 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Stephen J. Russell D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen J. Russell sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 110 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award

Overview

Stephen J. Russell is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on fields related to Medicine and Biochemistry, Genetics and Molecular Biology. Subfields of particular interest include Genetics, Molecular Biology, Epidemiology, Oncology, and Infectious Diseases.

Their work spans several key topics within biomedical research, notably virus-based gene therapy, CAR-T cell therapy, multiple myeloma research and treatments, SARS-CoV-2 and COVID-19, amyloidosis diagnosis and treatment, virology and viral diseases, and studies of animal virus infections.

Frequent publication venues for their research include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Journal of Clinical Oncology
  • Molecular Therapy - Oncolytics
  • Blood Cancer Journal

Stephen J. Russell has collaborated extensively with several co-authors, notably:

  • Martha Q. Lacy
  • Angela Dispenzieri
  • Francis K. Buadi
  • Morie A. Gertz
  • S. Vincent Rajkumar

Their recent notable publications include:

  • Mortality trends in multiple myeloma after the introduction of novel therapies in the United States, 2021, Leukemia
  • Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma, 2020, Leukemia
  • Redefining Pyropia (Bangiales, Rhodophyta): Four New Genera, Resurrection of Porphyrella and Description of Calidia pseudolobata sp. nov. From China, 2020, Journal of Phycology
  • Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update, 2021, Mayo Clinic Proceedings
  • Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins, 2021, Cell Reports Medicine

Best Publications

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Selection of phage antibodies by binding affinity. Mimicking affinity maturation.

    Robert E. Hawkins;Stephen J. Russell;Greg Winter

  • History of Oncolytic Viruses: Genesis to Genetic Engineering

    Elizabeth Kelly;Stephen J Russell

  • ONCOLYTIC VIROTHERAPY

    Unknown

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

    S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri

  • Engineering targeted viral vectors for gene therapy

    Reinhard Waehler;Stephen J. Russell;David T. Curiel

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation

    Noel M. Caplice;T. Jared Bunch;Paul G. Stalboerger;Shaohua Wang

  • Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

    Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri

  • High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.

    Bambi D. Anderson;Takafumi Nakamura;Stephen J. Russell;Kah Whye Peng

  • Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

    David Dingli;Kah Whye Peng;Mary E. Harvey;Philip R. Greipp

  • Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.

    S. Vincent Rajkumar;Ruben A. Mesa;Rafael Fonseca;Georgene Schroeder

  • Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

    Evanthia Galanis;Lynn C. Hartmann;William A. Cliby;Harry J. Long

  • The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

    Angela Dispenzieri;Martha Q. Lacy;Steven R. Zeldenrust;Suzanne R. Hayman

  • Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

    John A. Lust;Martha Q. Lacy;Steven R. Zeldenrust;Angela Dispenzieri

  • Rescue and propagation of fully retargeted oncolytic measles viruses.

    Takafumi Nakamura;Kah Whye Peng;Mary Harvey;Suzanne Greiner

  • Cancer gene therapy: hard lessons and new courses.

    R G Vile;S J Russell;N R Lemoine

  • Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.

    Eli Muchtar;Morie A. Gertz;Shaji K. Kumar;Martha Q. Lacy

  • Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Martha Q. Lacy;Jerry A. Katzmann;S. Vincent Rajkumar

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can expand your opportunities within the field of microbiology and healthcare. For instance, individuals with a criminal record often wonder about access to education; resources listing what can a felon go to college for provide valuable guidance on suitable online programs.

Healthcare-related careers with a science background include becoming a functional medicine nurse practitioner, where the functional medicine nurse salary is competitive and reflects specialized expertise.

Alternatively, those interested in administrative roles might consider certifications like becoming a certified professional coder. Career insights give a clear idea of the cpc salary and the advancement opportunities in medical coding.

For a blend of healthcare and management, a health information management degree offers robust career paths, with data on the health information management degree salary illustrating the financial benefits of this field.

Best Scientists Citing Stephen J. Russell

Trending Scientists